Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8341-8349

  Hunter, Kara ^a   Rainbow, Dan ^a   Plagnol, Vincent ^a   Todd, John A ^a   Peterson, Laurence B ^b   Wicker, Linda S ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; CATION TRANSPORT PROTEIN; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CHROMOSOME 1; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENE LOCUS; GENETIC SUSCEPTIBILITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ANIMAL; CHROMOSOME; CHROMOSOME MAP; CONGENIC STRAIN; GENE DOSAGE; GENETIC PREDISPOSITION; GENETICS; HUMAN;

ALLELES; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CATION TRANSPORT PROTEINS; CHROMOSOME MAPPING; CHROMOSOMES; DIABETES MELLITUS, TYPE 1; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, CONGENIC;

EID: 40049109288     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8341     Document Type: Article

References (34)

1. Hill, N. J., P. A. Lyons, N. Armitage, J. A. Todd, L. S. Wicker, and L. B. Peterson. 2000. The NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49: 1744-1747.
2. Lamhamedi-Cherradi, S. E., O. Boulard, C. Gonzalez, N. Kassis, D. Damotte, L. Eloy, G. Fluteau, M. Levi-Strauss, and H. J. Garchon. 2001. Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice. Diabetes 50: 2874-2878.
3. Wicker, L. S., G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. 2004. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173: 164-173.
4. Greve, B., L. Vijayakrishnan, A. Kubal, R. A. Sobel, L. B. Peterson, L. S. Wicker, and V. K. Kuchroo. 2004. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J. Immunol. 173: 157-163.
5. Howson, J. M., D. B. Dunger, S. Nutland, H. Stevens, L. S. Wicker, and J. A. Todd. 2007. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 50: 741-746.
6. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
7. Lynch, K. W., and A. Weiss. 2001. A CD45 polymorphism associated with multiple sclerosis disrupts an exonic splicing silencer. J. Biol. Chem. 276: 24341-24347.
8. Rothrock, C., B. Cannon, B. Hahm, and K. W. Lynch. 2003. A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45. Mol. Cell 12: 1317-1324.
9. Tong, A., J. Nguyen, and K. W. Lynch. 2005. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons. J. Biol. Chem. 280: 38297-38304.
10. Vijayakrishnan, L., J. M. Slavik, Z. Illes, R. J. Greenwald, D. Rainbow, B. Greve, L. B. Peterson, D. A. Hafler, G. J. Freeman, A. H. Sharpe, et al. 2004. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity 20: 563-575.
11. Fortier, A., G. Min-Oo, J. Forbes, S. Lam-Yuk-Tseung, and P. Gros. 2005. Single gene effects in mouse models of host: pathogen interactions. J. Leukocyte Biol. 77: 868-877.
12. Kissler, S., P. Stern, K. Takahashi, K. Hunter, L. B. Peterson, and L. S. Wicker. 2006. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38: 479-483.
13. Robles, D. T., G. S. Eisenbarth, N. J. Dailey, L. B. Peterson, and L. S. Wicker. 2003. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Diabetes 52: 882-886.
14. Lyons, P. A., and L. S. Wicker. 1999. Localising quantitative trait loci in the NOD mouse model of type 1 diabetes. In Genes and Genetics of Autoimmunity, Vol. 1. A. N. Theofilopoulos, ed. Karger, Basel, pp. 208-225.
15. Lyons, P. A., N. Armitage, F. Argentina, P. Denny, N. J. Hill, C. J. Lord, M. B. Wilusz, L. B. Peterson, L. S. Wicker, and J. A. Todd. 2000. Congenic mapping of the type 1 diabetes locus to a 780 kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 446-453.
16. Dovat, S., E. Montecino-Rodriguez, V. Schuman, M. A. Teitell, K. Dorshkind, and S. T. Smale. 2005. Transgenic expression of helios in B lineage cells alters B cell properties and promotes lymphomagenesis. J. Immunol. 175: 3508-3515.
17. + T cells from NOD congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J. Immunol. In press.
18. Guerra, C., R. A. Koza, K. Walsh, D. M. Kurtz, P. A. Wood, and L. P. Kozak. 1998. Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. J. Clin. Invest. 102: 1724-1731.
19. Cordell, H., J. Todd, N. Hill, C. Lord, P. Lyons, L. Peterson, L. Wicker, and D. Clayton. 2001. Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes. Genetics 158: 357-367.
20. Cannons, J. L., G. Chamberlain, J. Howson, L. J. Smink, J. A. Todd, L. B. Peterson, L. S. Wicker, and T. H. Watts. 2005. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes. J. Autoimmun. 25: 13-20.
21. Lundholm, M., V. Motta, A. Lofgren-Burstrom, N. Duarte, M. L. Bergman, S. Mayans, and D. Holmberg. 2006. Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 55: 538-544.
22. Prins, J. B., J. A. Todd, N. R. Rodrigues, S. Ghosh, L. S. Wicker, E. Gaffney, P. L. Podolin, P. A. Fischer, A. Sirotina, and L. B. Peterson. 1993. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science 260: 695-698.
23. Podolin, P. L., P. Denny, C. J. Lord, N. J. Hill, J. A. Todd, L. B. Peterson, L. S. Wicker, and P. A. Lyons. 1997. Congenic mapping of the insulin-dependent diabetes (Idd) gene: Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1. J. Immunol. 159: 1835-1843.
24. Roep, B. O., M. Atkinson, and M. von Herrath. 2004. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat. Rev. Immunol. 4: 989-997.
25. Ikegami, H., T. Awata, E. Kawasaki, T. Kobayashi, T. Maruyama, K. Nakanishi, A. Shimada, S. Amemiya, Y. Kawabata, S. Kurihara, et al. 2006. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab. 91: 1087-1092.
26. Koarada, S., Y. Wu, N. Fertig, D. A. Sass, M. Nalesnik, J. A. Todd, P. A. Lyons, J. Fenyk-Melody, D. B. Rainbow, L. S. Wicker, et al. 2004. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J. Immunol. 173: 2315-2323.
27. + T regulatory cells that inhibit the development of spontaneous autoimmune thyroiditis. J. Exp. Med. 203: 349-358.
28. Bottini, N., L. Musumeci, A. Alonso, S. Rahmouni, K. Nika, M. Rostamkhani, J. MacMurray, G. F. Meloni, P. Lucarelli, M. Pellecchia, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36: 337-338.
29. Smyth, D., J. D. Cooper, J. E. Collins, J. M. Heward, J. A. Franklyn, J. M. Howson, A. Vella, S. Nutland, H. E. Rance, L. Maier, et al. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53: 3020-3023.
30. Criswell, L. A., K. A. Pfeiffer, R. F. Lum, B. Gonzales, J. Novitzke, M. Kern, K. L. Moser, A. B. Begovich, V. E. Carlton, W. Li, et al. 2005. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet. 76: 561-571.
31. Carlton, V. E., X. Hu, A. P. Chokkalingam, S. J. Schrodi, R. Brandon, H. C. Alexander, M. Chang, J. J. Catanese, D. U. Leong, K. G. Ardlie, et al. 2005. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet. 77: 567-581.
32. Canton, I., S. Akhtar, N. G. Gavalas, D. J. Gawkrodger, A. Blomhoff, P. F. Watson, A. P. Weetman, and E. H. Kemp. 2005. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 6: 584-587.
33. Wu, H., R. M. Cantor, D. S. Graham, C. M. Lingren, L. Farwell, P. L. Jager, N. Bottini, J. M. Grossman, D. J. Wallace, B. H. Hahn, et al. 2005. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum. 52: 2396-2402.
34. Tait, K. F., J. E. Collins, J. M. Heward, I. Eaves, H. Snook, J. A. Franklyn, A. H. Barnett, J. A. Todd, M. Maranian, A. Compston, et al. 2004. Evidence for a Type 1 diabetes-specific mechanism for the insulin gene-associated IDDM2 locus rather than a general influence on autoimmunity. Diabetes Med. 21: 267-270.